Filing Details

Accession Number:
0001144204-14-050902
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-15 21:00:46
Reporting Period:
2014-08-12
Filing Date:
2014-08-15
Accepted Time:
2014-08-15 21:00:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571320 Paul Daniel Regan C/O Intercept Pharmaceuticals, Inc.
450 W. 15Th Street, Suite 505
New York NY 10011
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-12 8,124 $37.69 9,534 No 4 M Direct
Common Stock Disposition 2014-08-12 200 $305.39 9,334 No 4 S Direct
Common Stock Disposition 2014-08-12 100 $306.91 9,234 No 4 S Direct
Common Stock Disposition 2014-08-12 500 $310.10 8,734 No 4 S Direct
Common Stock Disposition 2014-08-12 500 $311.89 8,234 No 4 S Direct
Common Stock Disposition 2014-08-12 200 $312.78 8,034 No 4 S Direct
Common Stock Disposition 2014-08-12 800 $313.84 7,234 No 4 S Direct
Common Stock Disposition 2014-08-12 600 $314.93 6,634 No 4 S Direct
Common Stock Disposition 2014-08-12 200 $316.62 6,434 No 4 S Direct
Common Stock Disposition 2014-08-12 400 $317.71 6,034 No 4 S Direct
Common Stock Disposition 2014-08-12 400 $319.47 5,634 No 4 S Direct
Common Stock Disposition 2014-08-12 200 $321.44 5,434 No 4 S Direct
Common Stock Disposition 2014-08-12 100 $322.92 5,334 No 4 S Direct
Common Stock Disposition 2014-08-12 100 $326.03 5,234 No 4 S Direct
Common Stock Disposition 2014-08-12 300 $327.89 4,934 No 4 S Direct
Common Stock Disposition 2014-08-12 594 $329.59 4,340 No 4 S Direct
Common Stock Disposition 2014-08-12 206 $330.91 4,134 No 4 S Direct
Common Stock Disposition 2014-08-12 200 $331.92 3,934 No 4 S Direct
Common Stock Disposition 2014-08-12 100 $335.02 3,834 No 4 S Direct
Common Stock Disposition 2014-08-12 200 $336.47 3,634 No 4 S Direct
Common Stock Disposition 2014-08-12 100 $337.17 3,534 No 4 S Direct
Common Stock Disposition 2014-08-12 300 $341.21 3,234 No 4 S Direct
Common Stock Disposition 2014-08-12 300 $342.05 2,934 No 4 S Direct
Common Stock Disposition 2014-08-12 800 $343.80 2,134 No 4 S Direct
Common Stock Disposition 2014-08-12 500 $344.73 1,634 No 4 S Direct
Common Stock Disposition 2014-08-12 224 $346.68 1,410 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2014-08-12 8,124 $0.00 8,124 $37.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
101,875 2023-03-04 No 4 M Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2014.
  2. The remaining shares underlying this option vest on a pro rata monthly basis through March 4, 2017, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan.
  3. This transaction was executed in multiple trades at prices ranging from $305.32 to $305.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $309.7 to $310.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $311.27 to $312.165. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $312.32 to $313.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $313.43 to $314.265. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $314.54 to $315.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $316.195 to $317.045. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $317.58 to $317.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. This transaction was executed in multiple trades at prices ranging from $319.01 to $319.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. This transaction was executed in multiple trades at prices ranging from $321 to $321.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. This transaction was executed in multiple trades at prices ranging from $327.29 to $328.195. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. This transaction was executed in multiple trades at prices ranging from $329.11 to $330. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  15. This transaction was executed in multiple trades at prices ranging from $330.44 to $331.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  16. This transaction was executed in multiple trades at prices ranging from $331.8 to $332.1. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  17. This transaction was executed in multiple trades at prices ranging from $335 to $335.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  18. This transaction was executed in multiple trades at prices ranging from $336.16 to $336.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  19. This transaction was executed in multiple trades at prices ranging from $340.94 to $341.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  20. This transaction was executed in multiple trades at prices ranging from $341.97 to $342.155. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  21. This transaction was executed in multiple trades at prices ranging from $343.23 to $344.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  22. This transaction was executed in multiple trades at prices ranging from $344.275 to $345.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  23. This transaction was executed in multiple trades at prices ranging from $346.4 to $346.8. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.